title: Dinitrochlorobenzene therapy in alopecia areata.
abstract: With topical therapy using dinitrochlorobenzene (DNCB), 36 (72%) out of 50 patients having alopecia areata showed regrowth of hair in 3 to 6 months time. Five (10%) patients experienced marked vesiculation and severe contact dermatitis requiring cessation of therapy. In 7 (14%) patients there was no response at all and 4 (8%) presented with other side-effects.
authors.affiliation: Department of Medicine (Skin and Venereal Diseases), JN Medical College, Aligarh Muslim University.
authors.forename: A
authors.initials: A
authors.lastname: Kalam
authors.forename: M D
authors.initials: MD
authors.lastname: Tahseen
authors.forename: S F
authors.initials: SF
authors.lastname: Islam
authors.forename: M D
authors.initials: MD
authors.lastname: Rahmatullah
authors.forename: N A
authors.initials: NA
authors.lastname: Faruqi
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000506:Alopecia Areata / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004137:Dinitrochlorobenzene / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D004137:Dinitrochlorobenzene